ATP5F1E and tuberculosis: Because atpE and pepQ mutations were found to not confer high- or low-level BDQ resistance in this study and the existing Rv0678 mutations might not be associated with BDQ resistance, careful evaluation of the prescription of BDQ in the regimens for DR-TB treatment is recommended.